Long-term outcomes of breast cancer in women aged 30 years or younger, based on family history, pathology and BRCA1/BRCA2/TP53 status

Ítems similars

• Risk of Contralateral Breast Cancer in Women with and without Pathogenic Variants in BRCA1, BRCA2, and TP53 Genes in Women with Very Early-Onset (<36 Years) Breast Cancer
  per: Hyder, Zerin, et al.
  Publicat: (2020)
• brca2 and tp53 Collaborate in Tumorigenesis in Zebrafish
  per: Shive, Heather R., et al.
  Publicat: (2014)
• Risks of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
  per: Ahmed, M, et al.
  Publicat: (2010)
• Germline TP53 mutations in breast cancer families with multiple primary cancers: is TP53 a modifier of BRCA1?
  per: Martin, A, et al.
  Publicat: (2003)
• Phenocopies in BRCA1 and BRCA2 families: evidence for modifier genes and implications for screening
  per: Smith, A, et al.
  Publicat: (2007)